Several studies have reported elevated NF-κB activity in the cerebral cortex of individuals with AD, which may not only amplify inflammatory responses but also enhance BACE1 expression, thereby accelerating Aβ plaque development (Chen et al., 2012; Kaltschmidt et al., 2024). This evidence concerns the gene NFKB1 and Alzheimer disease.